ALBAINY-JENEI, STEPHEN, R.   FROST BROWN TODD LLC
58
Betreute Anmeldungen
Technische BereichePatente
Biotechnologie22
Pharmazeutika6
Grundsätzliche Werkstoffchemie6
Andere Spezialmaschinen5
Organische Feinchemie4

Heimatländer der Klienten

Zusammenfassung

ALBAINY-JENEI, Stephen, R. ist besonders erfahren in den Technologien „Biotechnologie“ und „Pharmazeutika“. 67% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „CHILDRENS HOSPITAL MEDICAL CENTER“ und „UNIVERSITY OF CINCINNATI“. Besonders viele Patentanmeldungen wurden in den Jahren 2005 und 2009 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

2
Patentanmeldungen
4
Patentanmeldungen
39
Patentanmeldungen
7
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1CHILDRENS HOSPITAL MEDICAL CENTERUSA13
2UNIVERSITY OF CINCINNATIUSA12
3TRANSPOSAGEN BIOPHARMACEUTICALS, INC.USA6
4US WORLDMEDS LLCUSA6
5AK STEEL PROPERTIES, INC.USA4
6CHILDRENS HOSPITAL RESEARCH FOUNDATIONUSA3
7INTERTHYR CORPORATIONUSA2
8AGEAN LLCUSA1
9ATRICURE, INC.USA1
10BATTELLE MEMORIAL INSTITUTEUSA1
11BRICHARD, INC.USA1
12CARBOLEX, INC.USA1
13CURIEL, DAVID, T.USA1
14DEBENEDETTI, ARRIGOUSA1
15ESTROCEPT DIAGNOSTICS, INC.USA1
16INTEGRATED BIOSCIENCE SOLUTIONS, LLCUSA1
17JEWISH HOSPITAL HEALTHCARE SERVICES, INC.USA1
18LOPEZ, RICHARDUSA1
19MATHIS, JAMES, MICHAELUSA1
20MOLECULAR RESEARCH CENTER, INC.USA1
21PICKNEY, BERTINEUSA1
22QUALEX MANUFACTURING, LCUSA1
23THE DUPPS COMPANYUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2011130381DIAGNOSTIC ASSAYS FOR BREAST CANCER TREATMENT AND PROGRESSIONESTROCEPT DIAGNOSTICS, INC.
2011
WO2011022634GENETICALLY MODIFIED RAT MODELS FOR PAINTRANSPOSAGEN BIOPHARMACEUTICALS, INC.
2011
WO2011022638TRP INHIBITORS AND USES THEREOFTRANSPOSAGEN BIOPHARMACEUTICALS, INC.
2011
WO2011017518GENETICALLY MODIFIED RAT MODELS FOR DRUG METABOLISMTRANSPOSAGEN BIOPHARMACEUTICALS, INC.
2011
WO2011014721GENETICALLY MODIFIED RAT MODELS FOR PHARMACOKINETICSTRANSPOSAGEN BIOPHARMACEUTICALS, INC.
2011
WO2011011678GENETICALLY MODIFIED RAT MODELS FOR CYTOKINE-CYTOKINE SIGNALING PATHWAYSTRANSPOSAGEN BIOPHARMACEUTICALS, INC.
2011
WO2010126818INTRANASAL DELIVERY SYSTEM FOR DANTROLENEUS WORLDMEDS LLC
2010
WO2010124200GENETICALLY MODIFIED RAT MODELS FOR CANCERTRANSPOSAGEN BIOPHARMACEUTICALS, INC.
2010
WO2010075275SELECTIVE RELEASE OF NON-RACEMIC MIXTURES OF TWO ENANTIOMERS FROM TABLETS AND CAPSULESUS WORLDMEDS LLC
2010
WO2010022326TRANSDERMAL DELIVERY OF APOMORPHINE USING MICRONEEDLESUS WORLDMEDS LLC
2010
WO2010016844LOFEXIDINE ENANTIOMERS FOR USE AS A TREATMENT FOR CNS DISEASE AND PATHOLOGIES AND ITS CHIRAL SYNTHESISAGEAN LLC
2010
WO2009158477SKIN PATCHES AND SUSTAINED-RELEASE FORMULATIONS COMPRISING LOFEXIDINE FOR TRANSDERMAL AND ORAL DELIVERYUS WORLDMEDS LLC
2009
WO2009149166METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISORDERSCHILDRENS HOSPITAL MEDICAL CENTER
2009
WO2009132257CYTOLOGICAL METHODS FOR DETECTING CANCERINTEGRATED BIOSCIENCE SOLUTIONS, LLC
2009
WO2009120735COMPOSITION AND METHOD FOR TRANSMUCOSAL DELIVERY OF LOFEXIDINEUS WORLDMEDS LLC
2009
WO2009117348REBOUND CONTROL MATERIALBATTELLE MEMORIAL INSTITUTE
2009
WO2009048698CO-SOLVENT COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF DANTROLENE THERAPEUTIC AGENTSUS WORLDMEDS LLC
2009
WO2009038816THERMOSETTING FIRE-RATED FIRE-RETARDANT POLYMERIC ADHESIVE COMPOSITIONPICKNEY, BERTINE
BRICHARD, INC.
LOPEZ, RICHARD
2009
WO2008143890BIOMARKERS FOR SEPTIC SHOCK PATIENTSCHILDRENS HOSPITAL MEDICAL CENTER
2008
WO2008140649BORON-DOPED SINGLE-WALLED NANOTUBES (SWCNT)CARBOLEX, INC.
2008
WO2008051818SPONTANEOUSLY FORMING ELLIPSOIDAL PHOSPHOLIPID UNILAMELLAR VESICLESCHILDRENS HOSPITAL MEDICAL CENTER
2008
WO2008048986GENE ARRAY TECHNIQUE FOR PREDICTING RESPONSE IN INFLAMMATORY BOWEL DISEASESCHILDRENS HOSPITAL MEDICAL CENTER
2008
WO2008002555METHOD AND APPARATUS FOR DETECTING UNSAFE CONDITIONSQUALEX MANUFACTURING, LC
2008
WO2007146161HIGH-ALUMINUM ALLOY FOR GENERAL GALVANIZINGUNIVERSITY OF CINCINNATI
2007
WO2007127439COMPOSITIONS COMPRISING FUSOGENIC PROTEINS OR POLYPEPTIDES DERIVED FROM PROSAPOSIN FOR APPLICATION IN TRANSMEMBRANE DRUG DELIVERY SYSTEMSCHILDRENS HOSPITAL MEDICAL CENTER
2007